Literature DB >> 10807512

The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites.

U Krzych1, R Schwenk, M Guebre-Xabier, P Sun, D Palmer, K White, I Chalom.   

Abstract

Exposure to irradiated Plasmodium sporozoites (gamma-spz) results in protection against malaria. Like infectious spz, gamma-spz colonize hepatocytes to undergo maturation. Disruption of liver stage development prevents the generation of protection, which appears, therefore, to depend on liver stage antigens. Although some mechanisms of protection have been identified, they do not include a role for intrahepatic mononuclear cells (IHMC). We demonstrated that P. berghei gamma-spz-immune murine IHMC adoptively transfer protection to naive recipients. Characterization of intrahepatic CD4+ T cells revealed an immediate, albeit transient, response to gamma-spz, while the response of CD8+ T cells is delayed until acquisition of protection. It is presumed that activated CD8+ T cells home to the liver to die; gamma-spz-induced CD8+CD45RB(lo)CD44(hi) T cells, however, persist in the liver, but not the spleen, during protracted protection. The association between CD8+CD45RB(lo)CD44(hi) T cells and protection has been verified using MHC class I and CD1 knockout mice and mice with disrupted liver stage parasites. Based on kinetic studies, we propose that interferon-gamma, presumably released by intrahepatic effector CD8+ T cells, mediates protection; the persistence of CD8+ T cells is, in turn, linked to Plasmodium antigen depots and cytokines released by CD4+ T cells and/or NK T cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807512     DOI: 10.1034/j.1600-0528.2002.00013h.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  19 in total

Review 1.  Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?

Authors:  Bruno Douradinha; Maria M Mota; Adrian J F Luty; Robert W Sauerwein
Journal:  Infect Immun       Date:  2007-12-03       Impact factor: 3.441

2.  Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A.

Authors:  Clara Brando; Lisa A Ware; Helen Freyberger; April Kathcart; Arnoldo Barbosa; Sylvie Cayphas; Marie-Ange Demoitie; Pascal Mettens; D Gray Heppner; David E Lanar
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

Review 3.  Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response.

Authors:  Michael Glen Overstreet; Ian Andrew Cockburn; Yun-Chi Chen; Fidel Zavala
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

4.  Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.

Authors:  Susanne Tartz; Jana Kamanova; Marcela Simsova; Peter Sebo; Stefanie Bolte; Volker Heussler; Bernhard Fleischer; Thomas Jacobs
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

5.  Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells.

Authors:  Ousman Jobe; Joanne Lumsden; Ann-Kristin Mueller; Jackie Williams; Hilda Silva-Rivera; Stefan H I Kappe; Robert J Schwenk; Kai Matuschewski; Urszula Krzych
Journal:  J Infect Dis       Date:  2007-07-09       Impact factor: 5.226

Review 6.  Immunity to liver stage malaria: considerations for vaccine design.

Authors:  Andrew W Taylor-Robinson
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

7.  Invariant Valpha14 chain NKT cells promote Plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producing CD8+ T cells in the liver after poxvirus vaccination of mice.

Authors:  Simone Korten; Richard J Anderson; Carolyn M Hannan; Eric G Sheu; Robert Sinden; Stephan Gadola; Masaru Taniguchi; Adrian V S Hill
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

8.  Memory CD8 T cells specific for plasmodia liver-stage antigens maintain protracted protection against malaria.

Authors:  Urszula Krzych; Sarat Dalai; Stasya Zarling; Alexander Pichugin
Journal:  Front Immunol       Date:  2012-12-10       Impact factor: 7.561

9.  Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates.

Authors:  Rhea J Longley; Ahmed M Salman; Matthew G Cottingham; Katie Ewer; Chris J Janse; Shahid M Khan; Alexandra J Spencer; Adrian V S Hill
Journal:  Sci Rep       Date:  2015-07-03       Impact factor: 4.379

10.  Skin-draining lymph node priming is sufficient to induce sterile immunity against pre-erythrocytic malaria.

Authors:  Michel Obeid; Jean-François Franetich; Audrey Lorthiois; Audrey Gego; Anne Charlotte Grüner; Maurel Tefit; Claude Boucheix; Georges Snounou; Dominique Mazier
Journal:  EMBO Mol Med       Date:  2012-12-19       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.